Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2015, Article ID 971321, 3 pages
http://dx.doi.org/10.1155/2015/971321
Case Report

Deep Venous Thrombosis with Pulmonary Embolism Related to IVIg Treatment: A Case Report and Literature Review

University of South Florida Morsani College of Medicine, 12901 Bruce B Downs Boulevard, MDC Box 19, Room L1041, Tampa, FL 33612, USA

Received 26 January 2015; Revised 6 May 2015; Accepted 7 May 2015

Academic Editor: Masahiro Kohzuki

Copyright © 2015 Michael T. Flannery and Deborah Humphrey. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. Chen, L. H. Danekas, T. A. Ratko, P. H. Vlasses, and K. A. Matuszewski, “A multicenter drug use surveillance of intravenous immunoglobulin utilization in US academic health centers,” Annals of Pharmacotherapy, vol. 34, no. 3, pp. 295–299, 2000. View at Publisher · View at Google Scholar · View at Scopus
  2. J. B. Caress, L. Hobson-Webb, L. V. Passmore, A. P. Finkbiner, and M. S. Cartwright, “Case-control study of thromboembolic events associated with IV immunoglobulin,” Journal of Neurology, vol. 256, no. 3, pp. 339–342, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Rakocevic and M. K. Floeter, “Autoimmune stiff person syndrome and related myelopathies: understanding of electrophysiological and immunological processes,” Muscle & Nerve, vol. 45, no. 5, pp. 623–634, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. I. Marie, G. Maurey, F. Hervé, M.-F. Hellot, and H. Levesque, “Intravenous immunoglobulin-associated arterial and venous thrombosis; report of a series and review of the literature,” British Journal of Dermatology, vol. 155, no. 4, pp. 714–721, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Paran, Y. Herishanu, O. Elkayam, L. Shopin, and R. Ben-Ami, “Venous and arterial thrombosis following administration of intravenous immunoglobulins,” Blood Coagulation and Fibrinolysis, vol. 16, no. 5, pp. 313–318, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Darnige and A. Lillo-Le Louët, “Treatments with immunoglobulin and thrombotic adverse events,” Revue de Medecine Interne, vol. 35, no. 1, pp. 39–44, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. M. C. Dalakas, “High-dose intravenous immunoglobulin and serum viscosity: risk of precipitating thromboembolic events,” Neurology, vol. 44, no. 2, pp. 223–226, 1994. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Ben-Ami, G. Barshtein, T. Mardi et al., “A synergistic effect of albumin and fibrinogen on immunoglobulin-induced red blood cell aggregation,” The American Journal of Physiology—Heart and Circulatory Physiology, vol. 285, no. 6, pp. H2663–H2669, 2003. View at Publisher · View at Google Scholar · View at Scopus
  9. B. M. Lapointe, L. M. Herx, V. Gill, L. M. Metz, and P. Kubes, “IVIg therapy in brain inflammation: etiology-dependent differential effects on leucocyte recruitment,” Brain, vol. 127, no. 12, pp. 2649–2656, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. A. S. Wolberg, R. H. Kon, D. M. Monroe, and M. Hoffman, “Coagulation factor XI is a contaminant in intravenous immunoglobulin preparations,” American Journal of Hematology, vol. 65, no. 1, pp. 30–34, 2000. View at Google Scholar
  11. R. Sztajzel, J. L. Floch-Rohr, and P. Eggimann, “High-dose intravenous immunoglobulin treatment and cerebral vasospasm: a possible mechanism of ischemic encephalopathy?” European Neurology, vol. 41, no. 3, pp. 153–158, 1999. View at Publisher · View at Google Scholar · View at Scopus
  12. R. Voltz, F. V. Rosen, T. Yousry, J. Beck, and R. Hohlfeld, “Reversible encephalopathy with cerebral vasospasm in a Guillain-Barré syndrome patient treated with intravenous immunoglobulin,” Neurology, vol. 46, no. 1, pp. 250–251, 1996. View at Publisher · View at Google Scholar · View at Scopus
  13. C. J. Glueck and P. Wnag, “Testosterone therapy, thrombosis, thrombophilia, cardiovascular events,” Metabolism: Clinical and Experimental, vol. 63, no. 8, pp. 989–994, 2014. View at Publisher · View at Google Scholar
  14. M. J. Cheng and C. Christmas, “Special considerations with the use of intravenous immunoglobulin in older persons,” Drugs and Aging, vol. 28, no. 9, pp. 729–736, 2011. View at Publisher · View at Google Scholar · View at Scopus